CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1

被引:0
|
作者
Aoki, Yoshitaka [1 ]
Yanaizu, Motoaki [1 ]
Ohki, Ai [1 ]
Nishimiya, Kai [1 ]
Kino, Yoshihiro [1 ]
机构
[1] Meiji Pharmaceut Univ, Dept RNA Pathobiol & Therapeut, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan
关键词
MUSCLEBLIND PROTEINS; SKELETAL-MUSCLE; LOCALIZATION;
D O I
10.1016/j.bbrc.2024.150729
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myotonic dystrophy type 1 (DM1) is caused by the expansion of a non-coding CTG repeat in DMPK. . CUG-repeat-containing transcripts sequester the splicing regulator MBNL1 into nuclear RNA foci, causing aberrant splicing of many genes. Although the mislocalization of MBNL1 represents a causal event in DM1 pathogenesis, the effect of CUG repeat RNA on the protein level of MBNL1 remains unclear. Using a DM1 model cell line, we found that CUG repeat RNA caused a significant decrease in the protein, but not mRNA levels, of MBNL1. As CUG repeats did not decrease MBNL1 translation, we investigated protein degradation pathways. Although autophagy-related reagents induced little change, proteasome inhibitors partially recovered MBNL1 protein expression levels under conditions of CUG repeat expression and induced a slight, but significant, reversal of splicing dysregulation. MBNL1 was detected in the polyubiquitinated protein fraction, but MBNL1 polyubiquitination was not detected. Moreover, inhibition of the ubiquitin-activating enzyme E1 did not increase MBNL1 levels, suggesting that MBNL1 is a substrate of polyubiquitin-independent proteasomal degradation. These results suggest that CUG-repeat-induced proteasomal degradation partially contributes to the functional decline of MBNL1.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy
    Guiying Chen
    Akio Masuda
    Hiroyuki Konishi
    Bisei Ohkawara
    Mikako Ito
    Masanobu Kinoshita
    Hiroshi Kiyama
    Tohru Matsuura
    Kinji Ohno
    Scientific Reports, 6
  • [2] Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy
    Chen, Guiying
    Masuda, Akio
    Konishi, Hiroyuki
    Ohkawara, Bisei
    Ito, Mikako
    Kinoshita, Masanobu
    Kiyama, Hiroshi
    Matsuura, Tohru
    Ohno, Kinji
    SCIENTIFIC REPORTS, 2016, 6
  • [3] MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1
    de Haro, Maria
    Al-Ramahi, Ismael
    De Gouyon, Beatrice
    Ukani, Lubna
    Rosa, Alberto
    Faustino, Nuno Andre
    Ashizawa, Tetsuo
    Cooper, Thomas A.
    Botas, Juan
    HUMAN MOLECULAR GENETICS, 2006, 15 (13) : 2138 - 2145
  • [4] Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy
    Chakraborty, Mouli
    Sellier, Chantal
    Ney, Michel
    Pascal, Villa
    Charlet-Berguerand, Nicolas
    Artero, Ruben
    Llamusi, Beatriz
    DISEASE MODELS & MECHANISMS, 2018, 11 (04)
  • [5] Role of RNA and MBNL1 Nuclear Foci in Pathomolecular Mechanism in Myotonic Dystrophy Type 1 and Type 2
    Meola, Giovanni
    Renna, Valentina
    Bugiardini, Enrico
    Giagnacovo, Marzia
    Pellicciari, Carlo
    Malatesta, Manuela
    Cardani, Rosanna
    NEUROLOGY, 2012, 78
  • [6] Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2
    Lukas, Z.
    Falk, M.
    Feit, J.
    Soucek, O.
    Falkova, I.
    Stefancikova, L.
    Janousova, E.
    Fajkusova, L.
    Zaoralkova, J.
    Hrabalkova, R.
    NEUROMUSCULAR DISORDERS, 2012, 22 (07) : 604 - 616
  • [7] A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL1
    Yu, Zhenming
    Goodman, Lindsey D.
    Shieh, Shin-Yi
    Min, Michelle
    Teng, Xiuyin
    Zhu, Yongqing
    Bonini, Nancy M.
    HUMAN MOLECULAR GENETICS, 2015, 24 (04) : 954 - 962
  • [8] A Novel CUGexp•MBNL1 Inhibitor with Therapeutic Potential for Myotonic Dystrophy Type 1
    Jahromi, Amin Haghighat
    Lien Nguyen
    Fu, Yuan
    Miller, Kali A.
    Baranger, Anne M.
    Zimmerman, Steven C.
    ACS CHEMICAL BIOLOGY, 2013, 8 (05) : 1037 - 1043
  • [9] MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1
    Huin, Vincent
    Vasseur, Francis
    Schraen-Maschke, Susanna
    Dhaenens, Claire-Marie
    Devos, Patrick
    Dupont, Kathy
    Sergeant, Nicolas
    Buee, Luc
    Lacour, Arnaud
    Hofmann-Radvanyi, Helene
    Sablonniere, Bernard
    JOURNAL OF NEUROLOGY, 2013, 260 (04) : 998 - 1003
  • [10] MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1
    Vincent Huin
    Francis Vasseur
    Susanna Schraen-Maschke
    Claire-Marie Dhaenens
    Patrick Devos
    Kathy Dupont
    Nicolas Sergeant
    Luc Buée
    Arnaud Lacour
    Hélène Hofmann-Radvanyi
    Bernard Sablonnière
    Journal of Neurology, 2013, 260 : 998 - 1003